Your new post is loading...
23andMe will use its genetic database for drug discovery. The company also picked former Roche executive Richard Scheller to lead the way.
Via Krishan Maggon
|
Rescooped by Anat Lechner from Pharma Biotech Industry Review (Krishan Maggon) |
Scoop.it!
Via Krishan Maggon
No comment yet.
Sign up to comment
